Literature DB >> 20149451

The characteristics of sub 10 nm manganese oxide T1 contrast agents of different nanostructured morphologies.

Chih-Chia Huang1, Ngee-Huat Khu, Chen-Sheng Yeh.   

Abstract

There is continuous interest in developing manganese-based T(1) contrast agents. While much effort has been made to synthesize manganese chelates, the development of manganese-based nanoparticle, particularly manganese oxides, as MRI contrast agents is burgeoning. In this report, sub-10-nm nanospheres, nanoplates, and nanocubes of Mn(3)O(4) were synthesized and exhibited paramagnetic behavior at room temperature on the basis of superconducting quantum interference devices (SQUID) measurements. The surface Mn(3+) passivated nanoplates examined by x-ray photoelectron spectroscopy (XPS) had the largest r(1) relaxivity of the reported manganese oxide nanoparticles. The MR labeling assays of Mn(3)O(4) nanoplate-treated A549 lung cancer cells showed that MR signals increased to 139% in T(1)-weighted images compared with untreated cells when the Mn ion concentration went down to 1.3 x 10(-2) mM. A dark field illumination microscope was employed to monitor Mn(3)O(4) nanoplates internalized into cells as a function of time. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20149451     DOI: 10.1016/j.biomaterials.2010.01.087

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  20 in total

1.  Manganese-based MRI contrast agents: past, present and future.

Authors:  Dipanjan Pan; Anne H Schmieder; Samuel A Wickline; Gregory M Lanza
Journal:  Tetrahedron       Date:  2011-11-04       Impact factor: 2.457

2.  Biocompatible and pH-sensitive PLGA encapsulated MnO nanocrystals for molecular and cellular MRI.

Authors:  Margaret F Bennewitz; Tricia L Lobo; Michael K Nkansah; Gözde Ulas; Gary W Brudvig; Erik M Shapiro
Journal:  ACS Nano       Date:  2011-05-03       Impact factor: 15.881

Review 3.  Functional magnetic nanoparticles for non-viral gene delivery and MR imaging.

Authors:  Ruijun Xing; Gang Liu; Jinghan Zhu; Yanglong Hou; Xiaoyuan Chen
Journal:  Pharm Res       Date:  2013-09-25       Impact factor: 4.200

4.  Intrinsically Zirconium-89-Labeled Manganese Oxide Nanoparticles for In Vivo Dual-Modality Positron Emission Tomography and Magnetic Resonance Imaging.

Authors:  Yonghua Zhan; Emily B Ehlerding; Sixiang Shi; Stephen A Graves; Shreya Goel; Jonathan W Engle; Jimin Liang; Weibo Cai
Journal:  J Biomed Nanotechnol       Date:  2018-05-01       Impact factor: 4.099

Review 5.  Biodegradable, polymer encapsulated, metal oxide particles for MRI-based cell tracking.

Authors:  Erik M Shapiro
Journal:  Magn Reson Med       Date:  2014-04-21       Impact factor: 4.668

6.  Highly water-dispersible calcium lignosulfonate-capped MnO nanoparticles as a T 1 MRI contrast agent with exceptional colloidal stability, low toxicity and remarkable relaxivity.

Authors:  Mahdi Arian; Ali Zamanian; Salman Taheri
Journal:  RSC Adv       Date:  2019-12-06       Impact factor: 4.036

7.  Radiolabeled, Antibody-Conjugated Manganese Oxide Nanoparticles for Tumor Vasculature Targeted Positron Emission Tomography and Magnetic Resonance Imaging.

Authors:  Yonghua Zhan; Sixiang Shi; Emily B Ehlerding; Stephen A Graves; Shreya Goel; Jonathan W Engle; Jimin Liang; Jie Tian; Weibo Cai
Journal:  ACS Appl Mater Interfaces       Date:  2017-10-24       Impact factor: 9.229

8.  Development of manganese-based nanoparticles as contrast probes for magnetic resonance imaging.

Authors:  Zipeng Zhen; Jin Xie
Journal:  Theranostics       Date:  2012-01-01       Impact factor: 11.556

9.  Relaxivity and toxicological properties of manganese oxide nanoparticles for MRI applications.

Authors:  Benedict You Wei Hsu; Georgia Kirby; Aaron Tan; Alexander M Seifalian; Xu Li; John Wang
Journal:  RSC Adv       Date:  2016-05-10       Impact factor: 4.036

10.  Ultrahigh relaxivity and safe probes of manganese oxide nanoparticles for in vivo imaging.

Authors:  J Xiao; X M Tian; C Yang; P Liu; N Q Luo; Y Liang; H B Li; D H Chen; C X Wang; L Li; G W Yang
Journal:  Sci Rep       Date:  2013-12-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.